Stifel analyst Stephen Willey maintains Zymeworks BC (NYSE:ZYME) with a Buy and lowers the price target from $21 to $18.
Analyst Expectations for Kemper’s Future
Within the last quarter, Kemper (NYSE:KMPR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…